Bayer Tagged Articles
FDA rejects blood thinner Eliquis
The Food and Drug Administration (FDA) voted not to approve the new blood thinner Eliquis (apixaban), surprising researchers and analysts alike. Eliquis, made by Squibb and Pfizer, was designed to go head-to-head with warfarin, an anticoagulant used to prevent strokes
FDA rejects Xarelto’s bid to treat acute coronary syndrome
The Food and Drug Administration (FDA) rejected expanding the indication for the new blood thinner Xarelto to prevent heart attacks and strokes in patients with a common heart condition known as acute coronary syndrome. The agency said there was too
Cancer drug fails to extend life in patients with advanced lung cancer
A drug tested in patients with advanced lung cancer has failed to increase the chances of survival. Nexavar (sorafenib), made by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, is already approved by the Food and Drug Administration (FDA) to treat some
Bayer shells out millions to settle more Yaz lawsuits
Bayer, maker of the blockbuster birth control pills Yaz and Yasmin, will pay at least $120 million to settle about 500 lawsuits claiming that the pills caused dangerous and sometimes deadly blood clots. The settlement is the first wave of
FDA puts stronger blood clot warnings on Yaz, Yasmin birth control pills
Yaz and other newer birth control pills that contain the hormone drospirenone will get stronger warnings on their labels warning users that the drugs may be more likely than older oral contraceptives to cause blood clots, the Food and Drug
Bayer settles a small fraction of Yaz, Yasmin lawsuits
Bayer has agreed to settle about 70 of the approximately 11,300 lawsuits against the drug giant involving its blockbuster birth control pills Yaz and Yasmin, according to the company’s 2011 annual report. The terms of the settlement were not disclosed,
Panel members had financial ties to Yaz maker
Why are the birth control pills Yaz and Yasmin still on the market when studies show they are more dangerous than other oral contraceptives?
Yaz lawyers oppose former FDA chief’s testimony
Drug giant Bayer is not at all happy that a former Food and Drug Administration (FDA) chief has been tapped to testify against the drug company in a multidistrict litigation (MDL) focusing on the safety of Bayer’s top-selling birth control
Drug company ‘check lists’ influence patient choice
How ethical is it for pharmaceutical companies to target consumers with advertising for their prescription drugs?
